The Relationship Between Prolanis Participation and Blood Sugar Control Among Type 2 Diabetes Mellitus Patients at Puskesmas Sindangkerta
DOI:
https://doi.org/10.62817/jkbl.v19i2.527Keywords:
Prolanis, type 2 diabetes mellitus, fasting blood glucose, cross-sectional studyAbstract
Outpatient visits for Type 2 Diabetes Mellitus at Puskesmas Sindangkerta increased from 122 to 269 patients from February 2024 to January 2025, with Diabetes Mellitus service coverage reaching 186.69% of the estimated target. The Chronic Disease Management Program (Prolanis) was designed to improve the quality of life of patients with chronic diseases; however, empirical evidence on its association with blood sugar control in primary care settings in West Bandung Regency remains limited. This study aimed to analyze the relationship between Prolanis participation and blood sugar control among patients with Type 2 Diabetes Mellitus at Puskesmas Sindangkerta. A quantitative cross-sectional study was conducted using secondary data from the Prolanis register and medical records of patients with Type 2 Diabetes Mellitus for the period from February 2025 to January 2026. The sample consisted of 55 respondents selected through total sampling and analyzed using the Chi-square test (α = 0.05). The results showed that 37 respondents (67.3%) actively participated in Prolanis, and 39 respondents (70.9%) had controlled fasting blood sugar levels. The Chi-square test showed a significant association (p < 0.001), with an odds ratio (OR) of 10.057 (95% CI: 2.643–38.276) and a prevalence ratio (PR) of 2.22 (95% CI: 1.23–4.03). Active Prolanis participants had a 2.22-fold higher prevalence of controlled blood sugar levels than inactive participants (PR = 2.22; 95% CI: 1.23–4.03). Optimization of Prolanis through digital technology and continuous education is needed to support Diabetes Mellitus control in primary care settings. These findings provide an empirical basis for strengthening Prolanis through active monitoring and continuous education to improve blood sugar control among patients with Type 2 Diabetes Mellitus in primary care settings
References
American Diabetes Association. (2023). Introduction and Methodology : Standards of Care in Diabetes — 2023. 46(December 2022), 1–4. https://doi.org/10.2337/dc23-Sint
American Diabetes Association. (2024). Introduction and Methodology : Standards of Care in Diabetes — 2024. 47(January), 1–4. https://doi.org/10.2337/dc24-SINT
Atto’illah, M. A., Anggraini, M. T., Lahdji, A., & Anggraheny, H. D. (2021). Keaktifan Mengikuti Prolanis Mempengaruhi Kestabilan Tekanan Darah pada Pasien Hipertensi di Puskesmas Warungasem Activeness of Prolanis Participation Influencing the Blood Pressure Stability in Hypertension Patients at Public Health Center Warungasem tar. 3(2). https://doi.org/10.26714/medart.3.2.2021.75-86
Badan Penyelenggara Jaminan Sosial (BPJS) Kesehatan. (2022). Panduan praktis Prolanis (Program pengelolaan penyakit kronis). Badan Penyelenggara Jaminan Sosial (BPJS). https://unitkesehatan.ipb.ac.id/wp-content/uploads/2022/07/PANDUAN-PROLANIS.pdf
Dinas Kesehatan Provinsi Jawa Barat. (2024). Jumlah Penderita Diabetes Melitus di Provinsi Jawa Barat Tahun 2023-2024. Open Data Jabar. https://opendata.jabarprov.go.id/id/dataset/jumlah-penderita-diabetes-melitus-berdasarkan-kabupatenkota-di-jawa-barat
Fachriany, C., Kadir, S., & Tuloli, T. S. (2026). JURNAL PROMOTIF PREVENTIF. 9(1), 36–42. https://doi.org/10.47650/jpp.v9i1.2425
International Diabetes Federation. (2024). Diabetes around the world - 2024 Diabetes around the world - 2024. https://diabetesatlas.org/resources/factsheets/
Kristianto, F. C., Sari, D. L., & Kirtishanti, A. (2021). Pengaruh Program Penanggulangan Penyakit Kronis ( PROLANIS ) terhadap Kadar Gula Darah Pasien Diabetes Melitus Tipe 2. 2(1), 8–14. https://doi.org/10.37148/comphijournal.v2i1.36
Pangesti, D. N. (2021). Kepatuhan mengikuti program pengelolaan penyakit kronis (Prolanis) dengan stabilitas gula darah pada penderita diabetes melitus. https://ejurnalmalahayati.ac.id/index.php/holistik/article/view/1774/pdf_1
PB PERKENI. (2024). Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 di Indonesia Tahun 2024. Pb Perkeni. https://pbperkeni.or.id/wp-content/uploads/2025/08/DMT2-2024-Protected.pdf
Putra, D. P., Syakurah, R. A., Idris, H., & Flora, R. (2024). THE RELATIONSHIP BETWEEN CHRONIC DISEASE MANAGEMENT PROGRAM ( PROLANIS ) FOR DIABETES MELLITUS AND OUTPATIENT VISITS DIABETES MELLITUS PATIENTS AT CLASS C PALEMBANG HOSPITALS IN 2023. 4(08), 6657–6664. https://doi.org/10.59188/eduvest.v4i8.1268
Rohmah, N. N., Waskito, B. A., Haryanti, E., Dokter, P., Kedokteran, F., Wijaya, U., Surabaya, K., Kedokteran, F., Wijaya, U., Surabaya, K., Penyakit, D., Fakultas, D., Universitas, K., Kusuma, W., Kupang, D., Surabaya, K., & Timur, J. (2023). Hubungan Prolanis dengan Pengendalian Gula Darah Penderita Diabetes Melitus Usia 35-65 Tahun di Puskesmas Pakis Surabaya. 1–9. https://erepository.uwks.ac.id/15027/13/JURNAL Nutdfah Nurmiftsa Rohmah 20700072.pdf
Widianingtyas, A., Purbowati, M. R., Dewantoro, L., & Mustikawati, I. F. (2021). Hubungan Keikutsertaan Prolanis (Program Pengelolaan Penyakit Kronis) dengan Tingkat Efikasi Diri Pasien Diabetes Mellitus Tipe 2 di Puskesmas 1 Kembaran. Muhammadiyah Journal of Geriatric, 1(2), 33. https://doi.org/10.24853/mujg.1.2.33-39
World Health Organization, G. strategy, & Digital, H. (2025). Global strategy on digital health. https://www.who.int/publications/i/item/9789240020924
Downloads
Published
How to Cite
Issue
Section
Citation Check
License
Copyright (c) 2026 Sri Wahyuni, Mochamad Rezha Alfiqri, Sri Atun, Ryka Juaeriah
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
